Women who enter menopause before the age of 40 are more likely to die young, but may lower their risk with hormone therapy, according to research presented at the 26th European Congress of Endocrinology in Stockholm.
Rocket Pharmaceuticals’ RP-A601 receives FDA designations
RP-A601 is designed to treat plakophilin-2-related arrhythmogenic cardiomyopathy (PKP2-ACM). Credit: Africa Studio via Shutterstock.com. Rocket Pharmaceuticals has received fast track and orphan drug designations for